Eight‐color multiparameter flow cytometry (EuroFlow‐NGF) is as sensitive as next‐generation sequencing in detecting minimal/measurable residual disease in autografts of patients with multiple myeloma. Issue 1 (24th January 2023)
- Record Type:
- Journal Article
- Title:
- Eight‐color multiparameter flow cytometry (EuroFlow‐NGF) is as sensitive as next‐generation sequencing in detecting minimal/measurable residual disease in autografts of patients with multiple myeloma. Issue 1 (24th January 2023)
- Main Title:
- Eight‐color multiparameter flow cytometry (EuroFlow‐NGF) is as sensitive as next‐generation sequencing in detecting minimal/measurable residual disease in autografts of patients with multiple myeloma
- Authors:
- Urushihara, Ryota
Takezako, Naoki
Yoroidaka, Takeshi
Yamashita, Takeshi
Murata, Ryoichi
Satou, Kenji
Nakao, Shinji
Takamatsu, Hiroyuki - Abstract:
- Abstract: The prognostic value of minimal/measurable residual disease (MRD) detection in autografts of patients with multiple myeloma (MM) in an autologous stem‐cell transplantation setting has been reported. Next‐generation flow (NGF) cytometry has lower sensitivity (2 × 10 −6 ) to detect MRD than next‐generation sequencing (NGS) (<10 −6 ). We compared the clinical value of high‐sensitivity NGF (cutoff: <10 −6 ) and NGS (cutoff: 10 −6 ) for the detection of MRD in the cryopreserved autografts of 49 patients with newly diagnosed MM. The sensitivity test using frozen/thawed autografts revealed a strong correlation among MRD levels of 5 × 10 −7 and 1 × 10 −4 ( r = 0.9997, p < 0.0001) when an adequate number of cells were analyzed. Autograft MRD levels determined using NGF and NGS were highly correlated ( r = 0.811, p < 0.0001). MRD‐negative patients identified with NGF (cutoff: <10 −6 ) showed significantly longer progression‐free survival (PFS) than MRD‐positive patients ( p = 0.026). The PFS of MRD‐negative patients determined by NGS (cutoff: 10 −6 ) was similar to that determined by NGF. These results show that the high‐sensitivity NGF method can assess MRD in frozen/thawed autografts, and its prognostic value is comparable to that of NGS.
- Is Part Of:
- EJHaem. Volume 4:Issue 1(2023)
- Journal:
- EJHaem
- Issue:
- Volume 4:Issue 1(2023)
- Issue Display:
- Volume 4, Issue 1 (2023)
- Year:
- 2023
- Volume:
- 4
- Issue:
- 1
- Issue Sort Value:
- 2023-0004-0001-0000
- Page Start:
- 184
- Page End:
- 191
- Publication Date:
- 2023-01-24
- Subjects:
- autologous peripheral blood stem‐cell transplantation -- minimal/measurable residual disease (MRD) -- multiparameter flow cytometry -- myeloma -- next‐generation sequencing
Hematology -- Periodicals
616.15 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
https://onlinelibrary.wiley.com/journal/26886146 ↗ - DOI:
- 10.1002/jha2.633 ↗
- Languages:
- English
- ISSNs:
- 2688-6146
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25764.xml